Concepedia

Shilpa Pandit

SP

Statistics

Publications

19

Citations

1.8K

H-Index

18

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Miami

United States Military Academy

Target (United States)

IRBM Science Park

Shilpa Pandit is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and natural sciences.

Top concepts

Publications per year

1998–2022

19

Publications

19

RNase G (CafA protein) and RNase E are both required for the 5′ maturation of 16S ribosomal RNA

Z. Li, Shilpa Pandit, Murray P. Deutscher · The EMBO Journal · 1999 · 268 citations · Full text

, , +13

Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH

Paola Lo Surdo, Matthew J. Bottomley, Alessandra Calzetta et al. · EMBO Reports · 2011 · 230 citations · Full text

, , +9

Effects of pH and Low Density Lipoprotein (LDL) on PCSK9-dependent LDL Receptor Regulation

Timothy S. Fisher, Paola Lo Surdo, Shilpa Pandit et al. · Journal of Biological Chemistry · 2007 · 187 citations · Full text

, , +15

3′ Exoribonucleolytic trimming is a common feature of the maturation of small, stable RNAs in <i>Escherichia coli</i>

Zhongwei Li, Shilpa Pandit, Murray P. Deutscher · Proceedings of the National Academy of Sciences · 1998 · 183 citations · Full text

, , +14

A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo1[S]

Ni Yan, Stefania Di Marco, Jon H. Condra et al. · Journal of Lipid Research · 2010 · 133 citations · Full text

1–5 of 19